How do we work with you?

CapEval Pharma has no proprietary projects or programs meaning that all of our clients are equally important to us. We welcome both short and long-term appointments and we offer our clients a flexible and cost effective approach based on their needs and scope of work.


 Projects can be undertaken at the offices of the client or from our offices in France, Geneva area. After initiating a CDA, to allow sharing of confidential information, we will provide a tailored contract stating the scope of work, proposed service arrangement and expected timeframe for the project. 

We offer the following flexible service arrangements to meet the needs of our clients and business partners

Competitive hourly rate

For less well defined projects and shorter term work

FFS (Fee For Service)

Pre-agreed fixed fee for a defined body of work

Full-Time-Equivalent (FTE)

A flat monthly rate which can be cost effective for larger scope projects

Milestone-type arrangement

Lower fee from the start with additional payments depending on predefined goals.

Dr. Olivier LOGET, DVM ERT,

CapEval Pharma CEO

  • More than 30 years of experience in pharma industry
  • Expert in Non-clinical safety and toxicology studies
  • Expert in drug development from clinical candidate selection through to entry into human
  • Eurotox Registered Toxicologist
  • President of International Society of ocular Toxicology: Dr. Loget is a lecturer teaching preclinical R&D, toxicology in drug development and ocular examination in several Research Institutes (INSERM, INRA), Universities and Veterinary Schools.
  • Expert in Due Diligence opportunities
  • Author or co-author of more than 20 publications

Our Expert Partner

Share by: